Roohi Mariam Peter

This month kicked off with one of the leading cancer summits in the U.S., where experts gather to present novel, promising cancer research at the American Society of Clinical Oncology (ASCO) in Chicago.

As stem cell research gains momentum, researchers are looking at ways to use the therapy to treat hearing loss.

A spate of royalty deals are changing the way certain biotechs press ahead, as seen with Cytokinetics’ agreement with Royalty Pharma.

2024 has witnessed the approval of a number of medicines including first-in-class drugs like Rezdiffra for chronic liver disease, Duvyzat for a rare

Explore five leading bioinformatics companies driving biopharma innovation in 2024 with advanced computer technology.

In this article, we take a look at six epigenetics companies that are significant as well as up-and-coming players in the industry.

Ipsen has lost a court case against the FDA to have its cancer medication Somatuline Depot regarded as a biologic instead of a drug.

Chimeric antigen receptor (CAR)-T therapy has been linked to serious side effects, following which U.S. regulators issued boxed warnings on the treatment.

In this article, we take a look at six biotech companies focused on bringing drugs to treat obesity to the market.

The therapeutic field of long non-coding (lnc) RNAs has flown under the radar for quite some time now since they emerged as targets belonging to the dark genome to treat various diseases.